9amHealth
$10.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
9amHealth is currently valued at N/A as of August 1, 2024. The company has raised a total of $38.4M in funding.
Investment Perspective
9amHealth's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is 9amHealth Worth in 2025?
As of 2025, 9amHealth is valued at N/A, based on the company's Debt - General funding round in August 1, 2024. This valuation positions 9amHealth as one of the leading private companies in the sector.
9amHealth Valuation History
9amHealth's funding history demonstrates steady growth and investor confidence.
How 9amHealth Valuation is Determined
Private company valuations like 9amHealth's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
9amHealth Valuation FAQs
Is 9amHealth profitable?
9amHealth has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does 9amHealth's valuation compare to competitors?
9amHealth is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will 9amHealth IPO?
9amHealth has not announced plans for an initial public offering. Until an IPO, investors can access 9amHealth shares through secondary market platforms.